Abiopharma

FDA approve METHADONE HYDROCHLORIDE

FDA approve PURIFIED WATER

General Announcement: COMPLETION OF THE PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TSKF

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD

Kymera Therapeutics Announces Pricing of $250 Million Public Offering

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Q & M Dental Group (Singapore) Limited - Announcement

Bristol Myers Squibb - U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels

U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels

U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.